Novai

Novai (United Kingdom, 2020). They have developed a biomarker called DARC that allows for the detection and imaging of individual stressed cells in the retina and uses this imaging data to predict disease progression. The AI-based platform, along with the biomarker, helps diagnose and predict the evolution of glaucoma and Age-related Macular Degeneration (AMD). It is formulated as an intravenous injection administered to the patient two hours before imaging.